FDx Advisors Inc. raised its position in Monsanto Company (NYSE:MON) by 26.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,344 shares of the company’s stock after acquiring an additional 3,186 shares during the quarter. FDx Advisors Inc.’s holdings in Monsanto were worth $1,838,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in MON. Pinnacle Financial Partners Inc. acquired a new stake in Monsanto in the second quarter valued at $114,000. Bruderman Asset Management LLC acquired a new stake in Monsanto in the second quarter valued at $116,000. Tower Research Capital LLC TRC lifted its stake in Monsanto by 230.1% in the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the company’s stock valued at $128,000 after acquiring an additional 750 shares during the last quarter. Armbruster Capital Management Inc. lifted its stake in Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the company’s stock valued at $136,000 after acquiring an additional 125 shares during the last quarter. Finally, Enterprise Financial Services Corp lifted its stake in Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the company’s stock valued at $164,000 after acquiring an additional 16 shares during the last quarter. Hedge funds and other institutional investors own 74.50% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://ledgergazette.com/2017/11/13/monsanto-company-mon-holdings-increased-by-fdx-advisors-inc.html.
In related news, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of C$122.00, for a total transaction of C$527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at C$5,903,336. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Nicole M. Ringenberg sold 7,890 shares of the firm’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of C$122.25, for a total transaction of C$964,552.50. Following the transaction, the vice president now directly owns 38,600 shares in the company, valued at C$4,718,850. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is owned by insiders.
A number of brokerages have commented on MON. UBS AG cut shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target for the company. in a research note on Friday, August 18th. BidaskClub cut shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Wednesday, August 30th. Piper Jaffray Companies set a $128.00 price target on shares of Monsanto and gave the company a “buy” rating in a research note on Friday, August 11th. Finally, Wells Fargo & Company increased their price target on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of C$124.61.
Monsanto Company (NYSE MON) traded down C$0.08 during trading hours on Monday, reaching C$118.22. 221,483 shares of the company were exchanged, compared to its average volume of 1,937,834. Monsanto Company has a 1-year low of C$97.35 and a 1-year high of C$122.79. The company has a market capitalization of $52,075.66, a price-to-earnings ratio of 21.39, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 4th. The company reported C$0.20 EPS for the quarter, topping analysts’ consensus estimates of C($0.41) by C$0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business had revenue of C$2.69 billion for the quarter, compared to analyst estimates of C$2.51 billion. During the same period last year, the firm earned $0.07 earnings per share. Monsanto’s revenue for the quarter was up 4.8% compared to the same quarter last year. analysts anticipate that Monsanto Company will post 5.74 EPS for the current fiscal year.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.